1. Home
  2. HCTI vs HCWB Comparison

HCTI vs HCWB Comparison

Compare HCTI & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

HOLD

Current Price

$5.87

Market Cap

3.3M

Sector

Technology

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$0.58

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCTI
HCWB
Founded
2020
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HCTI
HCWB
Price
$5.87
$0.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
6.1M
77.3K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
61.30
N/A
EPS
N/A
N/A
Revenue
$11,696,000.00
$4,099,750.00
Revenue This Year
$47.01
N/A
Revenue Next Year
$44.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.22
52 Week High
$20.42
$17.80

Technical Indicators

Market Signals
Indicator
HCTI
HCWB
Relative Strength Index (RSI) 70.01 23.60
Support Level $0.14 $0.53
Resistance Level $8.90 $0.67
Average True Range (ATR) 0.63 0.10
MACD 0.52 -0.03
Stochastic Oscillator 67.28 12.92

Price Performance

Historical Comparison
HCTI
HCWB

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: